105 related articles for article (PubMed ID: 23686119)
1. Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer.
Rittà M; Landolfo V; Mazibrada J; De Andrea M; Dell'Oste V; Caneparo V; Peretti A; Giordano C; Pecorari G; Garzaro M; Landolfo S
New Microbiol; 2013 Apr; 36(2):133-44. PubMed ID: 23686119
[TBL] [Abstract][Full Text] [Related]
2. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx.
Perrone F; Mariani L; Pastore E; Orsenigo M; Suardi S; Marcomini B; DaRiva L; Licitra L; Carbone A; Pierotti MA; Pilotti S
Cancer; 2007 Jun; 109(12):2461-5. PubMed ID: 17492690
[TBL] [Abstract][Full Text] [Related]
3. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
[TBL] [Abstract][Full Text] [Related]
4. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
[TBL] [Abstract][Full Text] [Related]
5. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus 16 Physical Status and the TP53 Codon 72 Polymorphism in Japanese HPV-Positive Oropharyngeal Cancer Patients.
Saito Y; Ando M; Fujimoto C; Omura G; Kobayashi K; Asakage T; Yamasoba T
ORL J Otorhinolaryngol Relat Spec; 2016; 78(1):46-54. PubMed ID: 26785263
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
8. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
[TBL] [Abstract][Full Text] [Related]
9. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
[TBL] [Abstract][Full Text] [Related]
10. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
Weinberger PM; Yu Z; Kountourakis P; Sasaki C; Haffty BG; Kowalski D; Merkley MA; Rimm DL; Camp RL; Psyrri A
Otolaryngol Head Neck Surg; 2009 Sep; 141(3):382-9. PubMed ID: 19716018
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 16 oropharyngeal cancers in lymph nodes as a marker of metastases.
Mirghani H; Moreau F; Lefèvre M; Tam C; Périé S; Soussan P; St Guily JL
Arch Otolaryngol Head Neck Surg; 2011 Sep; 137(9):910-4. PubMed ID: 21930979
[TBL] [Abstract][Full Text] [Related]
12. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.
van Kempen PM; Noorlag R; Swartz JE; Bovenschen N; Braunius WW; Vermeulen JF; Van Cann EM; Grolman W; Willems SM
Cancer Immunol Immunother; 2016 May; 65(5):575-85. PubMed ID: 26993499
[TBL] [Abstract][Full Text] [Related]
13. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
14. Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas.
Barbieri D; Nebiaj A; Strammiello R; Agosti R; Sciascia S; Gallinella G; Landini MP; Caliceti U; Venturoli S
J Clin Virol; 2014 Jul; 60(3):243-9. PubMed ID: 24845262
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the codon 72 polymorphism of TP53 and human papillomavirus infection in Iranian patients with prostate cancer.
Salehi Z; Hadavi M
J Med Virol; 2012 Sep; 84(9):1423-7. PubMed ID: 22825821
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
[TBL] [Abstract][Full Text] [Related]
17. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.
Rietbergen MM; Braakhuis BJ; Moukhtari N; Bloemena E; Brink A; Sie D; Ylstra B; Baatenburg de Jong RJ; Snijders PJ; Brakenhoff RH; Leemans CR
J Oral Pathol Med; 2014 Feb; 43(2):137-42. PubMed ID: 24118314
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and characteristics of HPV infection in oropharyngeal cancer.
De Stefani A; Boffano P; Averono G; Ramella A; Pia F; Bongioannini G
J Craniofac Surg; 2013 Jan; 24(1):e40-3. PubMed ID: 23348332
[TBL] [Abstract][Full Text] [Related]
20. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]